Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery.
D017088:AIDS-Related Opportunistic Infections / Q000276:immunology / Q000469:parasitology*; D000328:Adult; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D015497:HIV-1; D006801:Humans; D008297:Male; D014122:Toxoplasma; D014123:Toxoplasmosis / Q000209:etiology* / Q000276:immunology / Q000469:parasitology
D019380:Anti-HIV Agents